Lorenzo Di Cesare Mannelli
Overview
Explore the profile of Lorenzo Di Cesare Mannelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
293
Citations
3568
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lucarini E, DAntongiovanni V, Antonioli L, Ghelardini C, Di Cesare Mannelli L, Ferraroni M, et al.
ACS Med Chem Lett
. 2025 Feb;
16(2):347.
PMID: 39967648
[This corrects the article DOI: 10.1021/acsmedchemlett.4c00284.].
2.
Arias H, Micheli L, Jensen A, Galant S, Vandermoere F, Venturi D, et al.
Biomed Pharmacother
. 2025 Feb;
184:117887.
PMID: 39938347
The objective of this study was to determine the anti-neuropathic activity of a variety of ibogalogs, including tabernanthalog (TBG), ibogaminalog (DM506), ibogainalog (IBG), nor-IBG, catharanthalog (CAG), and PNU-22394 using the...
3.
Micheli L, Muraglia M, Corbo F, Venturi D, Clodoveo M, Tardugno R, et al.
Nutrients
. 2025 Jan;
17(1.
PMID: 39796555
Background: Oxaliplatin-induced neuropathy (OIN) is a severe painful condition that strongly affects the patient's quality of life and cannot be counteracted by the available drugs or adjuvants. Thus, several efforts...
4.
Micheli L, Balayssac D, Busserolles J, Dalbos C, Prival L, Richard D, et al.
Toxicology
. 2024 Nov;
510:153998.
PMID: 39551123
Peripheral nervous system (PNS) toxicity assessment in non-clinical safety studies is challenging and relies mostly on histopathological assessment. The present work aims to identify blood-based biomarkers that could detect peripheral...
5.
Micheli L, Nobili S, Lucarini E, Toti A, Margiotta F, Ciampi C, et al.
Pharmacol Res
. 2024 Oct;
209:107472.
PMID: 39448045
Growing evidence suggests that opioid analgesics modulate angiogenesis during pathophysiological processes. Vascular endothelial growth factor-A (VEGF-A) was recently proposed to be involved in pain development. To date, no anti-angiogenic drug...
6.
Lucarini E, Benvenuti L, Di Salvo C, DAntongiovanni V, Pellegrini C, Valdiserra G, et al.
Front Pharmacol
. 2024 Oct;
15:1466824.
PMID: 39372212
Introduction: Visceral pain represents the most common digestive issue, frequently resulting from long-term inflammation, such as inflammatory bowel diseases. The lack of effective drugs prompted search of new therapeutic approaches....
7.
Lucarini E, DAntogiovanni V, Antonioli L, Ghelardini C, Di Cesare Mannelli L, Ferraroni M, et al.
ACS Med Chem Lett
. 2024 Sep;
15(9):1559-1565.
PMID: 39291024
Carbonic anhydrase (CA) inhibitors represent intriguing tools for treating pain. This study aims at studying the pharmacological profile of chalcogen bioisosteres of aspirin, as inhibitors of CA isoforms (hCA I,...
8.
DAntongiovanni V, Pellegrini C, Benvenuti L, Fornai M, Di Salvo C, Natale G, et al.
Inflammation
. 2024 Sep;
PMID: 39276301
No abstract available.
9.
Micheli L, Vasarri M, DeglInnocenti D, Di Cesare Mannelli L, Ghelardini C, Emiliano A, et al.
Mar Drugs
. 2024 Jul;
22(7).
PMID: 39057409
Psoriasis is a chronic immune-mediated inflammatory cutaneous disease characterized by elevated levels of inflammatory cytokines and adipokine Lipocalin-2 (LCN-2). Recently, natural plant-based products have been studied as new antipsoriatic compounds....
10.
Micheli L, Pacini A, Di Cesare Mannelli L, Trallori E, DAmbrosio R, Bianchini C, et al.
Nutrients
. 2024 Jul;
16(13).
PMID: 38999922
In the original publication [...].